FinCEN’s De Facto Crypto Ban

TL;DR: Click here to comment on FinCEN’s rule-making. If you don't have time to write your own comment you can cut and copy the text at the bottom of this page and submit it as your own. A lot has been written about the Treasury Department and FinCEN's "midnight rulemaking" efforts regarding … Read more about FinCEN’s De Facto Crypto Ban

Overview of Marijuana Facility Licensing in Massachusetts

Medical + Recreational Under Massachusetts law, both medical and recreational marijuana are legal. The state is currently rolling out its recreational delivery program, as well as its social consumption establishment program. The state regulatory body, the Cannabis Control Commission (“CCC”), has … Read more about Overview of Marijuana Facility Licensing in Massachusetts

Oregon Takes the Lead on Drug Policy Reform

In the 2020 election, Oregon voters demonstrated an overwhelming appetite for drug policy reform. Election results show landslide victories for two groundbreaking measures – one decriminalizing all drugs, and one legalizing psilocybin-assisted clinical sessions. Both measures came to the ballot as … Read more about Oregon Takes the Lead on Drug Policy Reform

Is the DEA Coming for the Hemp Industry After All?

On August 20, 2020, the United States Drug Enforcement Administration (“DEA”) issued an interim final rule (“IFR”) pertaining to the classifications of marijuana and hemp under the federal Controlled Substances Act (“CSA”) in light of the 2018 Agricultural Improvement Act (“AIA”). Because the DEA … Read more about Is the DEA Coming for the Hemp Industry After All?

Section 1202 and QSBS, an Often Overlooked Tax Benefit for Small Businesses

          In the excitement of starting a new business, and during the headaches associated with growing that business, many entrepreneurs overlook important details that can have huge impacts on their finances. One large blind spot that many people we work with seem to have is the tax implications … Read more about Section 1202 and QSBS, an Often Overlooked Tax Benefit for Small Businesses

Vape and E-Cigarette Manufacturers Catch Another Break

This week, in a letter to federal Judge Paul Grimm, the U.S. Food and Drug Administration (“FDA”) requested a 120-day extension for e-cigarette product applications, citing the unforeseen impact of the novel coronavirus (“COVID-19”). This marks the most recent instance in a long line of delays, both … Read more about Vape and E-Cigarette Manufacturers Catch Another Break

FDA Recognizes the Need for CBD Regulation

On February 26, 2020 the Food and Drug Administration’s (“FDA”) new commissioner, Dr. Stephen Hahn, acknowledged the growing consumer demand for CBD products. “People are using these [CBD] products,” Hahn said in his first public speech regarding CBD since taking office in December. “We are not … Read more about FDA Recognizes the Need for CBD Regulation

USDA Comes to Its Senses Regarding Hemp

On February 27, 2020, the U.S. Department of Agriculture (“USDA”) announced that it will delay the enforcement requirement of the Drug Enforcement Agency (“DEA”) laboratory certification process and reverse distributer disposal requirements until October 31, 2021, or until the final rule is … Read more about USDA Comes to Its Senses Regarding Hemp